$6.19
1.75% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US74019L1070
Symbol
PRPO
Sector
Industry

Precipio, Inc. Stock price

$6.19
+1.11 21.85% 1M
-0.23 3.58% 6M
-0.31 4.77% YTD
-0.61 8.97% 1Y
-58.81 90.48% 3Y
-43.81 87.62% 5Y
-34,373.81 99.98% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.11 1.75%
ISIN
US74019L1070
Symbol
PRPO
Sector
Industry

Key metrics

Market capitalization $9.17m
Enterprise Value $9.06m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.54
P/S ratio (TTM) P/S ratio 0.55
P/B ratio (TTM) P/B ratio 0.75
Revenue growth (TTM) Revenue growth 52.61%
Revenue (TTM) Revenue $16.72m
EBIT (operating result TTM) EBIT $-5.59m
Free Cash Flow (TTM) Free Cash Flow $-1.09m
Cash position $1.28m
EPS (TTM) EPS $-2.68
P/E forward 3.61
P/S forward 0.37
EV/Sales forward 0.35
Short interest 0.16%
Show more

Is Precipio, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Precipio, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Precipio, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Precipio, Inc.:

Buy
100%

Financial data from Precipio, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
17 17
53% 53%
100%
- Direct Costs 11 11
27% 27%
65%
5.87 5.87
145% 145%
35%
- Selling and Administrative Expenses 9.97 9.97
15% 15%
60%
- Research and Development Expense - -
-
-
-4.10 -4.10
56% 56%
-25%
- Depreciation and Amortization 1.49 1.49
2% 2%
9%
EBIT (Operating Income) EBIT -5.59 -5.59
49% 49%
-33%
Net Profit -3.83 -3.83
65% 65%
-23%

In millions USD.

Don't miss a Thing! We will send you all news about Precipio, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Precipio, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
NEW HAVEN, Conn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) announces the Company's repricing of a portion of its employee stock options to ensure their effectiveness as a retention tool for valuable employees.
Neutral
Seeking Alpha
19 days ago
Precipio, Inc. (NASDAQ:PRPO ) Q2 2024 Earnings Conference Call August 19, 2024 5:00 PM ET Company Participants Ilan Danieli - Chief Executive Officer Operator Welcome to the Precipio Second Quarter 2024 Shareholder Update Conference Call. All participants will be in a listen-only mode.
Neutral
GlobeNewsWire
23 days ago
NEW HAVEN, Conn., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2024 corporate update call on August 19th at 5:00 PM ET.
More Precipio, Inc. News

Company Profile

Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Head office United States
CEO Ilan Danieli
Employees 57
Founded 1997
Website www.precipiodx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today